This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
“PROTAC 6” (GlaxoSmithKline (GSK) IAP-based selective RIPK2 degrader with prolonged in vivo PD)
molecule
2 years ago ●
1 min read
GSK620 (GlaxoSmithKline (GSK) oral in vivo BD2 domain selective BET inhibitor)
molecule
2 years ago ●
1 min read
Merck hArg1 inhibitor (Merck oral in vivo human arginase 1 inhibitor) DHMOTM2020-03-04
molecule
2 years ago ●
1 min read
Merck IDO1 inhibitor (Merck heme-displacing oral IDO1 inhibitor)
molecule
2 years ago ●
1 min read
Constellation EZH2 inhibitor (Constellation oral in vivo long-residence time EZH2 inhibitor)
molecule
2 years ago ●
1 min read
Arcus CD73 inhibitor (Arcus non-nucleoside CD73 inhibitor)
molecule
2 years ago ●
1 min read
Load More